N, N’-bidentate ligand anchored palladium catalysts on MOFs for efficient Heck reaction

Published in Materials
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

The Heck reaction is a cornerstone method for constructing C-C bonds in organic synthesis and the pharmaceutical industry. Since Mizoroki and Heck's groundbreaking work in the 1970s, where they reported the palladium-catalyzed cross-coupling of iodobenzene and olefin, the Heck reaction has become an indispensable tool in organic chemistry. The cinnamate esters produced through this reaction are widely used as food additives and serve as crucial intermediates in the synthesis of the anticancer drug paclitaxel.

In conventional Heck reaction systems, homogeneous palladium catalyst is commonly used as a catalyst. However, challenges such as recycling difficulties, high costs, and environmental pollution are frequently cited. Additionally, the presence of residual metals in final products poses a significant obstacle to the use of transition-metal catalysts in pharmaceutical synthesis. Therefore, the development of suitable heterogeneous catalysts is essential to overcome these challenges, protect the environment, and advance the principles of green chemistry.

In recent decades, researchers have extensively studied the incorporation of metal catalysts into metal-organic frameworks (MOFs) to develop effective heterogeneous catalysts. A common strategy involves coordinating catalytic centers with 2,2'-bipyridine-based ligands to form five-membered ring structures. Recently, we discovered that the two nitrogen atoms in the bipyridine ligand are part of a large π system, creating a rigid structure that could hinder optimal overlap with palladium's electron clouds. We proposed that the flexibility of the ligand's anchoring groups is crucial for maintaining crystallinity during metalation and coordination with metal centers. Thus, we have devised and synthesized a multifunctional ligand, 3-amino-4-(2-pyridyl) benzoic acid (APBA), derived from the 2-(2-aminophenyl) pyridine ligand, as illustrated in Figure 1. Compared to 2,2'-bipyridine, APBA offers enhanced flexibility in coordinating with palladium, thanks to the rotatable C–N bond in its amino group. Pd@MOF-APBA was synthesized according to Figure 1.

We characterized Pd@MOF-APBA using XRD, ICP, SEM, TEM, XPS, and XAS. To further elucidate its structure and catalytic activity, we also synthesized Pd@MOF-808, PdCl2@MOF-APBA, and Pd@MOF-BCA for comparison. The results demonstrated that the chelation of N, N'-bidentate ligands in Pd@MOF-APBA effectively immobilizes the palladium catalytic centers within MOF-808, postponing palladium leaching and agglomeration while maintaining high catalytic activity. Additionally, N2 adsorption-desorption isotherms confirmed that the ample pore size of MOF-808 can accommodate both APBA and palladium centers, providing sufficient space for catalytic reactions.

The synthesized catalyst exhibited excellent catalytic performance in the Heck cross-coupling reaction, achieving a high turnover number (TON) exceeding 95,000. Moreover, the catalyst can be recycled at least four times with a 100% yield, and up to three times even in gram-scale reactions, presenting itself as a promising candidate for heterogeneous catalysis in the pharmaceutical industry.

I would like to extend my gratitude to all the authors for their contributions to this work. Special thanks to Prof. Shuai Yuan, Prof. Yuanyuan Wang, the editor, and the reviewers for their invaluable suggestions throughout this project.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Materials Chemistry
Physical Sciences > Chemistry > Materials Chemistry

Related Collections

With collections, you can get published faster and increase your visibility.

Biology of rare genetic disorders

This cross-journal Collection between Nature Communications, Communications Biology, npj Genomic Medicine and Scientific Reports brings together research articles that provide new insights into the biology of rare genetic disorders, also known as Mendelian or monogenic disorders.

Publishing Model: Open Access

Deadline: Oct 30, 2024

Cancer epigenetics

With this cross-journal Collection, the editors at Nature Communications, Communications Biology, Communications Medicine, and Scientific Reports invite submissions covering the breadth of research carried out in the field of cancer epigenetics. We will highlight studies aiming at the improvement of our understanding of the epigenetic mechanisms underlying cancer initiation, progression, response to therapy, metastasis and tumour plasticity as well as findings that have the potential to be translated into the clinic.

Publishing Model: Open Access

Deadline: Oct 31, 2024